Table of Contents Author Guidelines Submit a Manuscript
Biochemistry Research International
Volume 2014 (2014), Article ID 291458, 7 pages
http://dx.doi.org/10.1155/2014/291458
Research Article

Serum Prolidase Activity and Oxidative Stress in Diabetic Nephropathy and End Stage Renal Disease: A Correlative Study with Glucose and Creatinine

1Department of Biochemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh 221005, India
2Department of Nephrology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh 221005, India
3Division of Biostatistics, Department of Community Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh 221005, India
4Department of Oral Pathology, Jaipur Dental College, Jaipur, Rajasthan 302020, India

Received 15 July 2014; Revised 21 August 2014; Accepted 21 August 2014; Published 8 September 2014

Academic Editor: Emanuel Strehler

Copyright © 2014 Akhilesh Kumar Verma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. E. Gilbert and M. E. Cooper, “The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?” Kidney International, vol. 56, no. 5, pp. 1627–1637, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. C. E. Mogensen, C. K. Christensen, and E. Vittinghus, “The stages in diabetic renal disease: with emphasis on the stage of incipient diabetic nephropathy,” Diabetes, vol. 32, no. 2, pp. 64–78, 1983. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Pickup and G. Williams, Text Book of Diabetes, Blackwell Science, 2nd edition, 1997.
  4. C. R. Kahn, G. C. Weir, G. L. King, A. M. Jacobson, A. C. Moses, and R. J. Smith, Joslin’s Diabetes Mellitus, Indian ed., Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 14th edition, 2005.
  5. A. C. Maritim, R. A. Sanders, and J. B. Watkins III, “Diabetes, oxidative stress, and antioxidants: a review,” Journal of Biochemical and Molecular Toxicology, vol. 17, no. 1, pp. 24–38, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Uzar, Y. Tamam, O. Evliyaoglu et al., “Serum prolidase activity and oxidative status in patients with diabetic neuropathy,” Neurological Sciences, vol. 33, no. 4, pp. 875–880, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Zanaboni, K. M. Dyne, A. Rossi, V. Monafo, and G. Cetta, “Prolidase deficiency: biochemical study of erythrocyte and skin fibroblast prolidase activity in Italian patients.,” Haematologica, vol. 79, no. 1, pp. 13–18, 1994. View at Google Scholar · View at Scopus
  8. I. Myara, A. Myara, M. Mangeot, M. Fabre, C. Charpentier, and A. Lemonnier, “Plasma prolidase activity: a possible index of collagen catabolism in chronic liver disease,” Clinical Chemistry, vol. 30, no. 2, pp. 211–215, 1984. View at Google Scholar · View at Scopus
  9. A. B. Erbagci, M. Araz, A. Erbağci, M. Tarakçioğlu, and E. S. Namiduru, “Serum prolidase activity as a marker of osteoporosis in type 2 diabetes mellitus,” Clinical Biochemistry, vol. 35, no. 4, pp. 263–268, 2002. View at Google Scholar
  10. M. Savas, E. Yeni, H. Celik et al., “The association of serum prolidase activity and erectile dysfunction,” Journal of Andrology, vol. 31, no. 2, pp. 146–154, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Kumari, A. K. Verma, S. Rungta, R. Mitra, R. Srivastava, and N. Kumar, “Serum prolidase activity, oxidant and anti-oxidant status in non-ulcer dyspepsia and healthy volunteers,” ISRN Biochemistry, vol. 2013, Article ID 182601, 6 pages, 2013. View at Publisher · View at Google Scholar
  12. M. Bergmann and J. S. Fruton, “On proteolytic enzymes, XII, regarding the specificity of aminopeptidase and carboxypeptidase, a new type of enzyme in the intestinal tract,” The Journal of Biological Chemistry, vol. 117, pp. 189–202, 1937. View at Google Scholar
  13. A. Surazynski, W. Miltyk, J. Palka, and J. M. Phang, “Prolidase-dependent regulation of collagen biosynthesis,” Amino Acids, vol. 35, no. 4, pp. 731–738, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. J. A. Palka and J. M. Phang, “Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors,” Journal of Cellular Biochemistry, vol. 67, pp. 166–175, 1997. View at Google Scholar
  15. O. Erel, “A novel automated method to measure total antioxidant response against potent free radical reactions,” Clinical Biochemistry, vol. 37, no. 2, pp. 112–119, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. O. Erel, “A new automated colorimetric method for measuring total oxidant status,” Clinical Biochemistry, vol. 38, no. 12, pp. 1103–1111, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. A. S. Levey, L. A. Stevens, C. H. Schmid et al., “A new equation to estimate glomerular filtration rate,” Annals of Internal Medicine, vol. 150, no. 9, pp. 604–612, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Susztak, A. C. Raff, M. Schiffer, and E. P. Böttinger, “Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy,” Diabetes, vol. 55, no. 1, pp. 225–233, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. R. P. Robertson, J. Harmon, P. O. T. Tran, and V. Poitout, “β-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes,” Diabetes, vol. 53, supplement 1, pp. S119–S124, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Shah, M. Iqbal, J. Karam, M. Salifu, and S. I. McFarlane, “Oxidative stress, glucose metabolism, and the prevention of type 2 diabetes: pathophysiological insights,” Antioxidants and Redox Signaling, vol. 9, no. 7, pp. 911–929, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. R. P. Robertson and J. S. Harmon, “Diabetes, glucose toxicity, and oxidative stress: a case of double jeopardy for the pancreatic islet β cell,” Free Radical Biology and Medicine, vol. 41, no. 2, pp. 177–184, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Srivastava, R. Lohokare, and R. Prasad, “Oxidative stress in children with bacterial meningitis,” Journal of Tropical Pediatrics, vol. 59, no. 4, pp. 305–308, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Srivastava, A. Kashyap, M. Kumar, G. Nath, and A. K. Jain, “Mucosal IgA & IL-1β in helicobacter pylori infection,” Indian Journal of Clinical Biochemistry, vol. 28, no. 1, pp. 19–23, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Monnier, E. Mas, C. Ginet et al., “Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes,” Journal of the American Medical Association, vol. 295, no. 14, pp. 1681–1687, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Terawaki, K. Yoshimura, T. Hasegawa et al., “Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin,” Kidney international, vol. 66, no. 5, pp. 1988–1993, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. K.-C. Huang, C.-C. Yang, K.-T. Lee, and C.-T. Chien, “Reduced hemodialysis-induced oxidative stress in end-stage renal disease patients by electrolyzed reduced water,” Kidney International, vol. 64, no. 2, pp. 704–714, 2003. View at Publisher · View at Google Scholar · View at Scopus